Revel Pharmaceuticals Company
Revel develops therapeutics for multiple diseases of aging including osteoarthritis, kidney disease, cardiovascular disease, skin aging, and complications of diabetes. It is commercializing therapeutic enzymes to degrade age-associated molecule damage.
Industry:
Geroscience
Headquarters:
San Francisco, California, United States
Zip:
1-10
Founded Date:
2019-01-01
Employees Number:
1-10
Acquisitions Number:
3
Investors Number:
8400000
Total Funding:
$1M to $10M
Estimated Revenue:
$1M to $10M
Last Funding Date:
Seed
Last Funding Type:
Seed
Register and Claim Ownership